Nanjing, China

Shousheng Yan

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Carefree Pharmaceutical Co., Ltd. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shousheng Yan. Retrieved from https://idiyas.com/inventor/shousheng-yan-difhs9mo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shousheng Yan: Innovator in Pharmaceutical Compounds

Introduction

Shousheng Yan is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions for treating complex medical conditions.

Latest Patents

Shousheng Yan holds a patent for a 4-substituted pyrrolo[2,3-d]pyrimidine compound. This invention relates to the use of this compound in preparing medications for treating JAK-targeted diseases, including rheumatoid arthritis and various immune system disorders. The experimental results indicate that this new compound demonstrates significant efficacy in inhibiting Janus kinases and the JAK-STAT pathway, as well as in reducing cell proliferation in human lymphocytoma.

Career Highlights

Shousheng Yan is associated with Jiangsu Carefree Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the understanding and treatment of diseases that affect millions of people worldwide.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Shousheng Yan's innovative work in developing pharmaceutical compounds showcases his commitment to improving healthcare outcomes. His contributions are vital in the ongoing fight against JAK-targeted diseases, and his patent reflects a significant advancement in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…